Decipher by Veracyte

Decipher by Veracyte Highly validated, commercially available genomic test predicting cancer aggressiveness in men with localized prostate cancer.

The Decipher Prostate Genomic Classifier by Veracyte provides meaningful and independent data to assess the underlying biology and risk of an individual patient’s disease. The test has been validated in over 75 studies of more than 60,000 patients as the most accurate predictor of metastasis, prostate cancer-specific mortality, and overall survival. Decipher Prostate Biopsy helps determine if pati

ents are suitable for active surveillance, if they need monotherapy, or if they may benefit from multi-modality or intensified therapy. Decipher Prostate RP helps determine treatment timing following radical prostatectomy and whether patients undergoing salvage radiotherapy may benefit from the addition of ADT. Developed from a large cohort of post-prostatectomy prostate cancer patients treated at the Mayo Clinic, with long-term follow-up, the whole-transcriptome test utilizes 22 coding and non-coding biomarkers that span seven cancer pathways to provide a more accurate, independent prediction of risk. When used in conjunction with clinical information, Decipher provides clarity and confidence in treatment planning. Decipher is covered by Medicare and many private insurance plans throughout the US. It is available to eligible US patients through their physicians. Learn more at www.veracyte.com/decipher

We're excited to be at the 2026 PAMA Convention in Palm Coast, FL, September 4-7. Visit the   booth to connect with our ...
09/05/2026

We're excited to be at the 2026 PAMA Convention in Palm Coast, FL, September 4-7. Visit the booth to connect with our team and learn how Decipher® Prostate and Decipher® Bladder testing can help support treatment planning in and .

We are at the Louisiana Urological Society (LUS) 2026 Annual Meeting in Bossier City, LA. Visit our booth today to learn...
08/22/2026

We are at the Louisiana Urological Society (LUS) 2026 Annual Meeting in Bossier City, LA. Visit our booth today to learn how testing by Veracyte, Inc. is helping transform care!

We’re here at the 2026 Joint Annual Meeting of the Oregon Urology Society and Washington State Urology Society in Steven...
08/15/2026

We’re here at the 2026 Joint Annual Meeting of the Oregon Urology Society and Washington State Urology Society in Stevenson, WA! Visit our booth today or tomorrow to learn how by Veracyte, Inc. is helping personalize & care!

08/12/2026
Stop by!   by Veracyte is at the 2026 Pennington Cancer Conference in Incline Village, NV. Visit our booth today to lear...
05/02/2026

Stop by! by Veracyte is at the 2026 Pennington Cancer Conference in Incline Village, NV. Visit our booth today to learn how we’re helping transform care!

We’re here!   by Veracyte, Inc. is at the 4th Annual Christopher G. Wood Advances in Urologic Oncology (UTMD) in San Ant...
04/11/2026

We’re here! by Veracyte, Inc. is at the 4th Annual Christopher G. Wood Advances in Urologic Oncology (UTMD) in San Antonio, TX. Visit our booth today to learn how we’re helping personalize care!

Address

6925 Lusk Boulevard
San Diego, CA
92121

Alerts

Be the first to know and let us send you an email when Decipher by Veracyte posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share